Skip to Main Content

1,585

Views

2

CrossRef citations to date

0

Altmetric

Letters to the Editor

Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)

Meagan A. Jacobya Washington University School of Medicine, St. Louis, MO, USACorrespondence[email protected]
View further author information

,

Laura Finnb Ochsner Health, New Orleans, LA, USAView further author information

,

Ashkan Emadic University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USAView further author information

,

Nakhle S. Sabad Tulane University School of Medicine, New Orleans, LA, USA

https://orcid.org/0000-0003-3206-2575 View further author information

,

Bayard L. Powelle Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USAView further author information

,

Karen Seiterf New York Medical College, Valhalla, NY, USAView further author information

,

Rosella Garciag Jazz Pharmaceuticals, Palo Alto, CA, USAView further author information

,

Stefan Faderlg Jazz Pharmaceuticals, Palo Alto, CA, USAView further author information

&

Heather J. Maleh University of Kansas Medical Center, Kansas City, KS, USAView further author information